Diclofenac (Sodium) (Standard)

Diclofenac (Sodium) (Standard) is the analytical standard of Diclofenac (Sodium) . This product is intended for research and analytical applications. Diclofenac Sodium (GP 45840) is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells[1], and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively[2]. Diclofenac Sodium induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade[3].

Product Specifications

CAS Number

[15307-79-6]

Product Name Alternative

GP 45840 (Standard)

UNSPSC

12352005

Hazard Statement

H301, H361, H372, H411

Target

Apoptosis; COX; Reference Standards

Type

Reference Standards

Related Pathways

Apoptosis; Immunology/Inflammation; Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology; Cancer

Assay Protocol

https://www.medchemexpress.com/diclofenac-sodium-standard.html

Purity

99.96

Smiles

O=C(O[Na])CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl

Molecular Formula

C14H10Cl2NNaO2

Molecular Weight

318.13

Precautions

H301, H361, H372, H411

References & Citations

[1]Riendeau D, et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol. 1997 May;121 (1) :105-17.|[2]Labib MB, et al. Design, synthesis of novel isoindoline hybrids as COX-2 inhibitors: Anti-inflammatory, analgesic activities and docking study. Bioorg Chem. 2018 Oct;80:70-80.|[3]Chiho Kudo, et al. Diclofenac Inhibits Proliferation and Differentiation of Neural Stem Cells. Biochem Pharmacol. 2003 Jul 15;66 (2) :289-95.